Victorian government funds paediatric cancer research
By Rob Clancy, staff writer
The future of children with cancer is brighter today, with the announcement of significant funding from the Victorian government for paediatric cancer research.
As a proud co-leader in the Victorian Paediatric Cancer Consortium (VPCC), Hudson Institute of Medical Research welcomes the commitment of $35 million, which will boost our efforts to find new treatments and cures, as well as improving quality of life for children who survive cancer.
Life-changing paediatric cancer research
Cancer remains the leading disease-related cause of death among Australian children and despite many years of research, survival rates from some cancers have hardly improved.
Working with our partners, the Children’s Cancer Foundation, which itself has committed $10 million to the VPCC, Hudson Institute scientists are proud to be at the forefront of this research.
Director and CEO of Hudson Institute, Professor Elizabeth Hartland, said this funding will allow our researchers to spend more time in the lab and less in search of the finance they need to carry out their vital work.
“Our scientists and clinicians are doing incredible, life-changing work, but too much of their time is spent outside the lab in the search for new sources of funding, so support like this provides the certainty they need to keep striving for the next research breakthrough.” Prof Hartland said.
“We are working toward new, personalised treatments for the nearly 1,000 Australian children – almost half of them under five – who are diagnosed with cancer every year.”
For interviews, please contact:
Rob Clancy, Communications & Media Manager
m: 0408 579 313
e: rob.clancy@hudson.org.au
In this article
About Hudson Institute
Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”